-
Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO)
2026-09-10
This scenario-driven guide explains how SKU K4001 supports protein degradation prevention in lysate workflows linked to cell viability, proliferation, cytotoxicity, and proteomic assays. It covers compatibility, dilution, DMSO controls, EDTA considerations, MS suitability, and practical product selection.
-
AEBSF.HCl Workflows for Protease Research
2026-09-09
AEBSF.HCl enables controlled, irreversible suppression of serine proteases in biochemical, cellular, amyloid, and immune-cell assays. This guide connects practical inhibitor workflows with lysosomal membrane permeabilization research while clarifying why AEBSF.HCl should not be treated as a direct cathepsin B inhibitor.
-
Solanesol B8776: Practical Hydrophobic Assay Guide
2026-09-09
Solanesol B8776 provides a defined polyisoprenoid alcohol for hydrophobic biochemical, membrane-related, enzyme, and selected cell-based workflows. It should be prepared in DMSO and used with solvent-matched controls; it is insoluble in water and ethanol and is not intended for diagnostic, clinical, or medical use.
-
N2703 Workflow for Adipose-Neural Assays
2026-09-08
Learn how to position 3-(1-methylpyrrolidin-2-yl)pyridine (N2703) as a controlled chemical perturbation in adipose-neural and cardiomyocyte experiments. The workflow emphasizes dose-finding, solvent control, orthogonal readouts, and careful separation between reference-study evidence and hypothesis-generating applications.
-
Sumatriptan Beyond Migraine: Anti-Inflammatory Evidence
2026-09-08
A systematic review by Ala and colleagues synthesizes evidence that sumatriptan may regulate inflammatory signaling beyond its established use in migraine. The review connects 5-HT1B/1D receptor activity with cytokine, nitric oxide, CGRP, caspase, and NF-κB pathways, while also highlighting the limitations of translating heterogeneous experimental findings into new clinical indications.
-
Polybrene Workflows for Efficient Gene Delivery
2026-09-07
Polybrene (Hexadimethrine Bromide) helps standardize viral attachment and uptake while also supporting difficult lipid-mediated DNA transfection workflows. This guide turns the reagent into a controlled optimization strategy and connects delivery controls with the mitochondrial OGDH biology highlighted in recent research.
-
Natural Compounds Against SARS-CoV-2: Docking Study
2026-09-07
This 2022 Journal of Molecular Modeling study used virtual screening, molecular docking, and molecular dynamics to evaluate natural compounds against the SARS-CoV-2 receptor-binding domain and 3CLpro. Its main contribution is a dual-target computational framework that identifies several vitamin-related molecules as candidates for blocking viral entry and replication, while also highlighting the need for biochemical and cellular validation.
-
LG 101506 in RXR Signaling Research
2026-09-05
Learn how to use LG 101506 as a controlled chemical probe for RXR biology, metabolism regulation, and nuclear receptor assays. This workflow pairs dose-response discipline with orthogonal readouts and a cautious, hypothesis-generating extension to PD-L1 research in triple-negative breast cancer.
-
Proteinase K Workflows for DNA Integrity
2026-09-04
Proteinase K combines broad protein digestion with compatibility across SDS, EDTA, and flexible temperature conditions, making it a practical choice for genomic DNA isolation and enzyme contaminant removal. This guide translates its biochemical strengths—and its distinct role as a control protease in SARS-CoV-2 3CLpro research—into executable workflows and troubleshooting decisions.
-
LRPPRC–Dasatinib Dual OXPHOS Disruption
2026-09-04
The reference study identifies dasatinib as a synergistic partner for LRPPRC inhibition in OXPHOS-dependent cancer models. Its central innovation is a dual-genome mechanism: dasatinib preferentially suppresses nuclear-encoded OXPHOS genes, while LRPPRC inhibition disrupts mitochondrial genome-encoded OXPHOS expression, providing a rationale for combination therapy in LRPPRC-high tumors.
-
3X (DYKDDDDK) Peptide for EMC Workflows
2026-09-03
The 3X (DYKDDDDK) Peptide supports sensitive FLAG-based capture, elution, and detection while preserving options for membrane-complex studies. This practical guide connects FLAG workflows with EMC structural biology, including cryo-EM sample preparation, metal-sensitive assays, and troubleshooting.
-
From P2RX1 Biology to Better Apoptosis Decisions
2026-09-03
A translational framework for connecting P2RX1-driven mitochondrial stress in Ph+ ALL with rapid, decision-ready apoptosis and necrosis measurements using the Annexin V-Cy5/DAPI Apoptosis Kit.
-
Pertussis toxin: Immune Assay Workflow Guide
2026-09-02
Learn how to use Pertussis toxin as a controlled cAMP-pathway perturbation in dendritic-cell, T-cell, and vascular assays. This workflow guide emphasizes dose-finding, orthogonal readouts, storage discipline, and careful interpretation alongside the Dhx9–TH17 research framework.
-
25-Hydroxycholesterol Reprograms TAM Metabolism
2026-09-02
Xiao et al. identify CH25H-derived 25-hydroxycholesterol as an immunometabolic checkpoint that links lysosomal lipid sensing to AMPKα–STAT6 signaling and ARG1 production in tumor-associated macrophages. Their findings show that targeting this axis can increase T-cell activity and improve anti-PD-1 responses, while also providing a framework for studying metabolic interventions in the tumor microenvironment.
-
LAG-3–TCR Proximity in T Cell Suppression
2026-09-01
A 2025 Cell study shows that LAG-3 inhibition depends less on MHC class II binding alone than on LAG-3 being positioned near the T cell receptor. The work identifies disruption of CD3ε–Lck association as a mechanism and develops an Fc-attenuated LAG-3/TCR bispecific antibody that suppresses pathogenic CD4+ and CD8+ T cells in autoimmune models.